Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADVENT: Crofelemer for HIV-Associated Diarrhea
NCT00547898Phase 3Completed
- Sponsor
- Valeant Pharmaceuticals
- Start
- Oct 2007
- Primary completion
- Jan 2011
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of crofelemer in HIV-associated diarrhea, sponsored by Valeant Pharmaceuticals. Started Oct 2007; status: completed.
02
Drugs
crofelemer
03
Conditions
HIV-associated diarrhea
Beyond the preview
Go deeper on NCT00547898.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00547898.